<DOC>
	<DOCNO>NCT00122850</DOCNO>
	<brief_summary>This study examine duloxetine compare placebo active comparator treatment generalize anxiety disorder .</brief_summary>
	<brief_title>A Comparison Duloxetine Hydrochloride , Marketed Comparator , Placebo Treatment Generalized Anxiety Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Venlafaxine Hydrochloride</mesh_term>
	<mesh_term>Duloxetine Hydrochloride</mesh_term>
	<criteria>Male female outpatient least 18 year age , present generalize anxiety disorder ( GAD ) base disease diagnostic criterion . Must suffer GAD adjustment disorder anxiety disorder otherwise specify . The symptom GAD situational nature . Any current primary DSMIV Axis I diagnosis GAD , include : Patients diagnose major depressive disorder within past 6 month ; Patients diagnose panic disorder , posttraumatic stress disorder within past year ; Patients diagnose obsessivecompulsive disorder , bipolar affective disorder , psychosis , factitious disorder , somatoform disorder lifetimes . The presence Axis II disorder history antisocial behavior , , judgement investigator , would interfere compliance study protocol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2007</verification_date>
</DOC>